Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Buckley Capital. This analysis is provided for institutional research purposes only and is not investment advice.
"Small-cap value manager targeting 20% annual returns through concentrated positions in undervalued Russell 2000 names. Portfolio includes IWG at 7.5x earnings with 25% growth, new aviation connectivity play Gogo with 300% upside, and fitness franchisor XPOF expecting 100-200% returns."
Buckley Capital delivered 2.0% net returns in 2024, underperforming benchmarks but maintaining strong 5-year track record of 19% annualized returns. Manager believes current environment mirrors 2000 when small caps were positioned to outperform after period of large-cap dominance. Portfolio consists of undervalued Russell 2000 names trading at significant discounts to intrinsic value, contrasting with overvalued large-cap names like Apple and Tesla. Key positions include IWG trading at 7.5x earnings with 25% projected growth, new position Gogo with 300% upside potential from aviation connectivity consolidation, Xponential Fitness expecting 100-200% upside as franchise issues resolve, and Dentalcorp trading at 8-9x FCF versus peers at 20x+. Manager targets high teens to low 20s percent net returns over next 5 years, expecting Russell 2000 to generate 7-10% returns versus 5-7% for S&P 500. Portfolio success viewed as near-foregone conclusion given diversification across multiple undervalued businesses with substantial value gaps.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High conviction evidenced by concentrated portfolio with named, sized positions including largest holding IWG and detailed analysis of specific companies. Manager provides specific price targets (Gogo $30 by 2028, XPOF $30-40 in 1-2 years) and declares portfolio success 'near-foregone conclusion.' However, some hedging language and acknowledgment of recent underperformance prevents maximum score.
Growth Outlook
Manager expresses constructive optimism about small-cap opportunities and Russell 2000 prospects, expecting 7-10% returns versus 5-7% for S&P 500. However, acknowledges overvaluation in large-cap markets and describes 2024 as 'not our best year,' balancing positive outlook with realistic assessment.
Risk Appetite
Portfolio remains concentrated in undervalued small-cap names with manager adding new position in Gogo and maintaining conviction in existing holdings. Describes portfolio success as 'near-foregone conclusion' and targets aggressive 20% annual returns, indicating strong risk appetite and commitment to current positioning.
Capital Deployment
Manager initiated new position in Gogo and maintains existing concentrated holdings, but no evidence of significant cash deployment or major position sizing changes. Activity appears selective rather than aggressive, with focus on maintaining current positioning rather than major capital deployment.
Forward Guidance
Manager provides specific return targets and maintains existing positions but does not indicate aggressive new deployment. Guidance is measured with focus on patience and long-term value realization rather than immediate scaling of positions.
Language Signal
Language is balanced between opportunity identification and risk acknowledgment. While manager highlights undervaluation and upside potential, also acknowledges recent underperformance and uses measured language about forward prospects. Net balance is slightly positive but not overwhelmingly bullish.
Perceived Risk
Manager acknowledges overvaluation risk in large-cap markets and describes 2024 as challenging year, but risk discussion is limited and not central to the letter. Primary focus is on opportunities rather than systemic risks, with standard acknowledgment of market uncertainties.
Opportunity Density
Manager sees abundant opportunities in small-cap value space, describing multiple undervalued names with significant upside potential. Specific examples provided across different sectors (fitness, aviation, dental, workspace) with detailed analysis of value gaps and catalysts for each position.
Time Horizon
Manager emphasizes long-term value realization with 5-year return targets and discussion of multi-year catalysts. Gogo analysis includes 2028 price targets, and overall approach focuses on patient capital with 3-5 year thesis timeframes. However, some near-term catalyst dependency prevents higher score.
